News in the Life Sciences Industry

STOCKHOLM, May 23, 2019 /PRNewswire/ -- Cyxone (publ.), a Swedish biotech in autoimmune diseases, today announced that the company has set a date for the application submission for the start of clinical trials with T20K. On Monday May 27, an application to the relevant authorities to start... Read more ››

STOCKHOLM, May 23, 2019 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the company has recruited the internationally renowned scientist Dr. Per-Ola Freskgård to strengthen BioArctic's development of its technology platform to facilitate passage of antibodies... Read more ››

STOCKHOLM, May 23, 2019 /PRNewswire/ -- Essity, the global hygiene and health company, is holding its Investor Day today in Stockholm, Sweden. Presentations will be held by the President and CEO as well as members of Executive Management Team and representatives of Essity's subsidiary Vinda,... Read more ››

STOCKHOLM, May 23, 2019 /PRNewswire/ -- Valuable knowledge about PMS & PMDD will be shared at the University of Gothenburg on May 28 at a public evening of talks, lectures and Q&A. Prof Torbjörn Bäckström, PMDD research pioneer and Asarina Pharma CSO, will speak about the science... Read more ››

STOCKHOLM, May 22, 2019 /PRNewswire/ -- Today on 22 May 2019, Q-linea AB (publ) (Nasdaq Stockholm: QLINEA) held its annual general meeting for the financial year 2018 in Uppsala, whereby the following resolutions were adopted.

STOCKHOLM, May 22, 2019 /PRNewswire/ -- Elekta (EKTA-B.ST) today announced that Elekta Unity, a transformative magnetic resonance radiation therapy (MR/RT) system that enables personalized precision radiation medicine, is in clinical use at The Christie NHS Foundation Trust. Elekta Unity combines... Read more ››

LUND, Sweden, May 22, 2019 /PRNewswire/ --

STOCKHOLM, May 22, 2019 /PRNewswire/ -- This statement is made by the Board of DirectorsRead more ››

STOCKHOLM, May 22, 2019 /PRNewswire/ -- Biovica has a comprehensive study program with DiviTum® to demonstrate the clinical value for cancer patients. Biovica has published a summary brochure in order to share knowledge about results achieved so far with DiviTum® to researchers, oncologists... Read more ››

STOCKHOLM, May 21, 2019 /PRNewswire/ -- Essity is divesting its 50% stake in the partly owned company SCA Yildiz in Turkey to the other part owner Yildiz.

STOCKHOLM, May 21, 2019 /PRNewswire/ -- "The initiation of the filing process for melflufen in the US is a major milestone for Oncopeptides."

STOCKHOLM, May 21, 2019 /PRNewswire/ -- Important events January-March 2019

STOCKHOLM, May 20, 2019 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the company will receive a milestone payment of MEUR 15 from its partner Eisai for the achievement of the first patient being dosed in the global, single confirmatory Phase 3 study (Clarity... Read more ››